{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:12:40Z","timestamp":1782601960760,"version":"3.54.5"},"reference-count":132,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T00:00:00Z","timestamp":1449619200000},"content-version":"vor","delay-in-days":4847,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1046\/j.1523-1755.2002.00500.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:50:38Z","timestamp":1047462638000},"page":"733-744","source":"Crossref","is-referenced-by-count":52,"title":["\u201cBlack swan in the kidney\u201d: Renal involvement in the antiphospholipid antibody syndrome"],"prefix":"10.1016","volume":"62","author":[{"given":"Chike M.","family":"Nzerue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlene","family":"Hewan-Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pierangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Nigel","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0010","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease and lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"BMJ"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0015","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0020","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/archinte.1986.00360230069012","article-title":"Thrombosis, recurrent fetal loss and thrombocytopenia: Predictive value of anticardiolipin antibody test","volume":"146","author":"Harris","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/26.5.324","article-title":"Syndrome of the black swan","volume":"265","author":"Harris","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1529-0131(200002)43:2<440::AID-ANR26>3.0.CO;2-N","article-title":"Validation of the Sapporo criteria for antiphospholipid syndrome","volume":"43","author":"Lockshin","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0040","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","article-title":"Genetic susceptibility to venous thrombosis","volume":"344","author":"Seligsohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0045","series-title":"Hematology","first-page":"1715","article-title":"Lupus anticoagulant and related disorders,","author":"Rand","year":"2001"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0050","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/art.1780310818","article-title":"Anticardiolipin antibodies in lyme disease","volume":"31","author":"Macworth-Young","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0055","first-page":"18","article-title":"The development of antiphospholipid antibodies in hemophilia is liked to infection with hepatitis C","volume":"58","author":"Al-Saeed","year":"1994","journal-title":"Br J Hematol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0060","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Antiphospholipid antibodies are directed against a complex antigen that includes lipid binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0065","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor","volume":"355","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0070","first-page":"565","article-title":"Beta 2 glycoprotein I (beta 2-GPI) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies","volume":"82","author":"Pierangeli","year":"1992","journal-title":"Br J Immunol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0075","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(98)10362-8","article-title":"Antiphospholipid antibodies and thrombosis","volume":"353","author":"Greaves","year":"1999","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jaut.2000.0420","article-title":"Experimental thrombosis and antiphospholipid antibodies","volume":"15","author":"Pierangeli","year":"2000","journal-title":"New Insights J Autoimmun"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0085","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1172\/JCI119401","article-title":"Anti-beta 2-glycoprotein I (beta 2-GPI) monoclonal antibodies with lupus anticoagulant activity enhance the beta 2-GPI binding to phospholipids","volume":"99","author":"Takeya","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0090","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipids with Protein C or Protein S: An explanation for their pathogenic mechanism","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0037-1614977","article-title":"The role of tissue factor pathway in the hypercoagutable state in patients with antiphospholipid antibody syndrome","volume":"79","author":"Amengual","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-2141.1998.00841.x","article-title":"1gG from patients with antiphospholipid syndrome binds to platelets without induction of platelet activation","volume":"102","author":"Ford","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0105","first-page":"36","article-title":"The pathogenesis of the antiphospholipid antibody syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia","volume":"75","author":"Arnout","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0002-9378(12)90915-1","article-title":"Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome. A possible mechanism of thrombosis","volume":"168","author":"Branch","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0115","series-title":"Winthrobes Clinical Hematology","first-page":"1782","article-title":"Thrombosis and antithrombotic therapy,","author":"ROGERS","year":"1999"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0120","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and invivo","volume":"99","author":"Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0125","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1006\/bbrc.1994.2833","article-title":"Lupus anticoagulant autoantibody induced apoptosis in umbilical vein endothelial cells: Involvement of annexin V","volume":"205","author":"Nakamura","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0130","first-page":"179","article-title":"Activation of cultured vascular endothelial cells by antiphospholipid antibodies","volume":"13","author":"Simantov","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1 and P-selectin","volume":"88","author":"Pierangeli","year":"2001","journal-title":"Circ Res"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02231583","article-title":"Circulating intercellular adhesion molecules-1 and autoantibodies in including antiendothelial cells anticardiolipin and antineutrophil cytoplasmic antibodies in patients with vasculitis","volume":"12","author":"Wang","year":"1993","journal-title":"Clin Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0145","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJM198605013141817","article-title":"Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant","volume":"314","author":"Carion","year":"1986","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1046\/j.1523-1755.2002.00500.x_bb0150","first-page":"S132","article-title":"Antiphospholipid antibodies and myocardial infarction","volume":"7","author":"Vaarcola","year":"1998","journal-title":"Lupus"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0155","first-page":"621","article-title":"A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus","volume":"31","author":"Conley","year":"1952","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0160","first-page":"416","article-title":"Thrombosis in systemic lupus erythematosus: Despite a circulating anticoagulant","volume":"62","author":"Bowie","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005792-198103000-00001","article-title":"Glomerular thrombosis in systemic lupus erythematosus: Prevalence and significance","volume":"60","author":"Kant","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies, anticardiolipin and the lupus (SLE) and non SLE disorders","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0175","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jama.1988.03720040042024","article-title":"The relationship between lupus anticoagulants and antibodies to phospholipids","volume":"259","author":"Triplett","year":"1988","journal-title":"JAMA"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0002-9343(90)90458-P","article-title":"Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activator partial thromboplastin hives","volume":"85","author":"Alving","year":"1990","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0185","first-page":"795","article-title":"Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure","volume":"69","author":"Kincaid-Smith","year":"1988","journal-title":"Q J Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0272-6386(12)80543-9","article-title":"Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome","volume":"20","author":"Hughson","year":"1992","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000013615","article-title":"Anticardiolipin antibodies in South African patients with lupus nephritis","volume":"20","author":"Naiker","year":"2000","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0200","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ki.1991.155","article-title":"Significance of antiphospholipid antibodies in patients with lupus nephritis","volume":"39","author":"Frampton","year":"1991","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0272-6386(12)80885-7","article-title":"Renal vascular lesions as a marker for poor prognosis in patients with lupus nephritis","volume":"18","author":"Banfi","year":"1991","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/096120339400300106","article-title":"Renal biopsy in SLE: Significance of glomerular thrombosis. Analysis of 108 cases","volume":"3","author":"Miranda","year":"1994","journal-title":"Lupus"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0272-6386(12)70258-5","article-title":"Lupus anticoagulant in systemic lupus erythematosus: A clinical and renal pathological study","volume":"20","author":"Farrugia","year":"1992","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","article-title":"Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis","volume":"91","author":"Bandari","year":"1998","journal-title":"Q J Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0225","first-page":"437","article-title":"Influence of disease duration, continued follow-up and further antiphospholipid antibody testing on the frequency and classification category of antiphopholipid syndrome in a cohort of patients with SLE","volume":"20","author":"Perez-Vaquez","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/rheumatology\/30.6.422","article-title":"Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis","volume":"30","author":"Leaker","year":"1991","journal-title":"Br J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0235","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM200104123441508","article-title":"Rapidly progressive renal failure in a 35-year-old woman with SLE. Case Records of Massachusetts General Hospital. Case 11\u20132001","volume":"344","author":"Coggins","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","article-title":"Antiphospholipid nephropathy in systemic lupus erythematosus","volume":"13","author":"Daugas","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08860229909066969","article-title":"Catastrophic antiphospholipid syndromes in systemic lupus erythematosus","volume":"21","author":"Stratta","year":"1999","journal-title":"Ren Fail"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0250","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intra renal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0255","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000187378","article-title":"Acute renal failure as the first clinical manifestation of the primary antiphospholipid antibody syndrome","volume":"64","author":"Lacueva","year":"1993","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1681\/ASN.V4128","article-title":"Reversible renal failure in the primary antiphospholipid syndrome. A report of two cases","volume":"3","author":"Sokunbi","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0265","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.V15777","article-title":"Anticardiolipin antibody and renal disease. A report of three cases","volume":"1","author":"D'Agati","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0270","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000046236","article-title":"Primary antiphospholipid antibody syndrome and mesangial 1gA glomerulonephritis","volume":"21","author":"Simniah","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000045482","article-title":"IgA nephropathy and antiphospholipid syndrome","volume":"83","author":"Silva","year":"1999","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0280","first-page":"1289","article-title":"Primary antiphospholipid antibody syndrome with multiorgan arterial and venous thrombosis","volume":"19","author":"Perez","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0285","first-page":"874","article-title":"Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome","volume":"20","author":"Asherson","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1096-8652(200010)65:2<154::AID-AJH11>3.0.CO;2-A","article-title":"Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)","volume":"65","author":"Triplett","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archinte.1991.00400020007001","article-title":"An acute disseminated coagulopathy-vasculopathy associated with the antiphospholipid antibody syndrome","volume":"151","author":"Harris","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0300","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1681\/ASN.V5111882","article-title":"Catastrophic secondary antiphospholipid syndrome with concomitant antithrombin III deficiency","volume":"5","author":"Peddi","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/jaut.2000.0423","article-title":"Kidney involvement in the antiphospholipid syndrome","volume":"15","author":"Nochy","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0310","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome. Clues to pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0315","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","article-title":"The renal pathology of primary antiphospholipid syndrome: A distinctive form of endothelial injury","volume":"93","author":"Griffiths","year":"2000","journal-title":"Q J Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0320","first-page":"252","article-title":"Catastrophic antiphospholipid syndrome associated with crescentic glomerulonephritis: A clinicopathologic case","volume":"18","author":"Cisternas","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0325","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0272-6386(96)90109-2","article-title":"Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old in with primary antiphospholipid syndrome","volume":"27","author":"Poux","year":"1996","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0330","first-page":"471","article-title":"Post partum hemolytic-uremic syndrome associated with lupus anticoagulant","volume":"44","author":"Gherman","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000168432","article-title":"Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. A case report and literature review","volume":"12","author":"Knauz","year":"1992","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0340","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ndt\/4.10.854","article-title":"Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant","volume":"4","author":"Kleinknecht","year":"1989","journal-title":"Nephrol Dial Transpl"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0345","first-page":"479","article-title":"Malignant hypertension in anti phospholipid syndrome without overt lupus nephritis","volume":"11","author":"Caccoub","year":"1993","journal-title":"Clin Exp Rheum"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0350","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0895-7061(00)00296-X","article-title":"Hypertension due to renal artery occlusion in a patient with the antiphospholipid syndrome","volume":"14","author":"Riccialdelli","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0355","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000189092","article-title":"Malignant hypertension in antiphospholipid syndrome","volume":"73","author":"Sirvent","year":"1996","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0360","first-page":"417","article-title":"Renovascular hypertension associated with antiphospholipid antibodies in a woman with systemic lupus erythematosus","volume":"38","author":"Serino","year":"1996","journal-title":"Jap J Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0365","first-page":"1802","article-title":"Bilateral renal artery occlusion in a patient with primary antiphospholipid syndrome: Thrombosis, vasculitis or both","volume":"19","author":"Ames","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0370","first-page":"1413","article-title":"Hypertension, renal artery stenosis and primary antiphospholipid syndrome","volume":"18","author":"Asherson","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0375","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/ard.51.10.1180-b","article-title":"Anticardiolipin antibodies and renovascular hypertension","volume":"51","author":"Rossi","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0380","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bmj.300.6741.1696","article-title":"Raised concentrations of antibodies to cardiolipin in patients receiving dialysis","volume":"300","author":"Gronhagen-Riska","year":"1990","journal-title":"Br Med J"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000184984","article-title":"Lupus-like in vitro anticoagulant activity in end-stage renal disease","volume":"49","author":"Quereda","year":"1988","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0390","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000187422","article-title":"Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy compared to patients with systemic lupus erythematosus. An epiphenomenon?","volume":"64","author":"Sitter","year":"1993","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0395","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","article-title":"Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease","volume":"6","author":"Garcia Morton","year":"1991","journal-title":"Nephrol Dial Transpl"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0400","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0272-6386(12)80378-7","article-title":"Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus","volume":"23","author":"Quereda","year":"1994","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0405","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ki.1995.352","article-title":"Antiphospholipids in hemodialysis patients. Relationship between lupus anticoagulant and thrombosis","volume":"48","author":"Brunet","year":"1995","journal-title":"Kid Int"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0003-4975(99)00458-0","article-title":"Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients","volume":"68","author":"Fastenau","year":"1999","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 2","key":"10.1046\/j.1523-1755.2002.00500.x_bb0415","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1177\/096120339800700213","article-title":"Origin of antiphospholipid antibodies: Induction by viral peptides","volume":"7","author":"Gharavi","year":"1998","journal-title":"Lupus"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0049-3848(93)90212-7","article-title":"Beta 2-Glycoprotein I-dependent and independent anticardiolipin antibody in patients with end-stage renal disease","volume":"72","author":"Matsuda","year":"1993","journal-title":"Thromb Res"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0425","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01698134","article-title":"Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus","volume":"65","author":"Sitter","year":"1992","journal-title":"Annal Hematol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0430","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000187511","article-title":"Prevalence of lupus anticoagulant and anticardiolipin antibodies in dialysis patients","volume":"65","author":"Philips","year":"1993","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0435","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/7.12.1194","article-title":"Are antiphospholipid antibodies clinically relevant in dialysis patients?","volume":"14","author":"Chew","year":"1992","journal-title":"Nephrol Dial Transp"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0440","first-page":"89","article-title":"Antiphospholipid (APL) antibodies in end-stage renal disease","volume":"12","author":"Fabrizi","year":"1999","journal-title":"J Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0445","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0272-6386(12)80383-0","article-title":"Frequent hemodialysis graft thrombosis: Association with antiphospholipid antibodies","volume":"23","author":"Prieto","year":"1994","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0450","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","article-title":"Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis","volume":"26","author":"Prakash","year":"1995","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0455","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000045833","article-title":"Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: Cause or effect?","volume":"86","author":"Haviv","year":"2000","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0460","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1072-7515(99)00086-1","article-title":"Thrombotic complications resulting from hypercoagutable states in chronic hemodialysis vascular access","volume":"189","author":"Lesar","year":"1999","journal-title":"J Am Coll Sur"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0465","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00007890-199901150-00015","article-title":"Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients","volume":"67","author":"Ducloux","year":"1999","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0470","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0272-6386(12)80986-3","article-title":"Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients","volume":"23","author":"Radhakrishnan","year":"1994","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0475","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00041552-200103000-00004","article-title":"Antiphospholipid antibody and renal disease","volume":"10","author":"Joseph","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0480","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70009-0","article-title":"Antiphospholipid antibody syndrome in renal transplantation: Occurrence of clinical events in 96 consecutive patients with system lupus erythematosus","volume":"34","author":"Stone","year":"1999","journal-title":"Am J Kid Dis"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0485","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1681\/ASN.V101146","article-title":"Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive allograft recipients","volume":"10","author":"Baid","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0490","first-page":"S117","article-title":"Adverse outcome after renal transplantation in two patients with the primary antiphospholipid syndrome","volume":"36","author":"Amigo","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0495","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2141.2000.01812.x","article-title":"High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation","volume":"108","author":"Mengarelli","year":"2000","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1046\/j.1523-1755.2002.00500.x_bb0500","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s001470050280","article-title":"Risk of early allograft failure is increased for patients with antiphospholipid antibodies","volume":"13","author":"Wagen Knecht","year":"2000","journal-title":"Transpl Int"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0505","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00007890-199907270-00014","article-title":"Antiphosphospholipid and antibodies are a risk factor for early renal allograft failure","volume":"68","author":"Wagen Knecht","year":"1999","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0510","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-0012.1998.tb00995.x","article-title":"Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies","volume":"12","author":"Vaidya","year":"1998","journal-title":"Clin Transpl"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0515","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0140-6736(92)91897-H","article-title":"Induction of thrombosis within renal grafts by high dose prophylactic OK T3","volume":"339","author":"Abramowicz","year":"1992","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0520","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00007890-199804150-00013","article-title":"Early loss of renal transplants in patients with thrombophilia","volume":"65","author":"Fischereder","year":"1998","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0525","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199410270-00012","article-title":"Natural anticoagulant and fibrinolytic pathways in renal allograft failure","volume":"58","author":"Torry","year":"1994","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0530","first-page":"219","article-title":"Vascular lesions in biopsy specimens devoid of cellular infiltrates: qualitative and quantitative immunocytochemical studies of cardiac allografts","volume":"12","author":"Faulk","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0535","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.1997.03550140061041","article-title":"Endothelial activation and development of coronary artery disease in heart-transplant recipients","volume":"278","author":"Labarrere","year":"1997","journal-title":"JAMA"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0540","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0041-1345(98)01629-7","article-title":"Antiphospholipid antibodies are implicated in early renal allograft failure: isolation of APA from a thrombosed renal allograft","volume":"31","author":"Wagen Knecht","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0545","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0049-3848(92)90063-G","article-title":"Interaction of heparin with beta2-glycoprotein I and antiphospholipid antibodies in vitro","volume":"68","author":"Wagen Knecht","year":"1992","journal-title":"Thromb Res"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0550","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/oxfordjournals.ndt.a091729","article-title":"Allograft membranous glomerulonephritis and renal vein thrombosis in a patient with a lupus anticoagulant factor","volume":"3","author":"Liano","year":"1988","journal-title":"Nephrol Dial Transpl"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000046220","article-title":"Acute renal failure in a renal transplant donor due to primary antiphospholipid syndrome","volume":"21","author":"Chitalia","year":"2001","journal-title":"Am J Nephrol"},{"issue":"Suppl 2","key":"10.1046\/j.1523-1755.2002.00500.x_bb0560","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1177\/096120339800700232","article-title":"Diagnosis of antiphospholipid antibody syndrome: a proposal for use of laboratory tests","volume":"7","author":"Harris","year":"1998","journal-title":"Lupus"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0565","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02069.x","article-title":"Guidelines on the investigation and management of the antiphospholipid syndrome","volume":"109","author":"Greaves","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0570","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00003081-200103000-00007","article-title":"Testing for antiphospholipid antibodies: problems and solutions","volume":"44","author":"Pierangeli","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0575","first-page":"591","article-title":"Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissues","volume":"26","author":"Merkel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000045472","article-title":"Anticardiolipin antibodies in acute post-streptococcal glomerulonephritis and streptococcal impetigo","volume":"83","author":"Ardiles","year":"1999","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0585","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jaut.2000.0419","article-title":"Equivocal antiphospholipid syndrome","volume":"15","author":"Harris","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0590","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/35.12.1239","article-title":"Specificity of ELISA for antibody to beta2-glycoprotein I in patients with antiphospholipid syndrome","volume":"35","author":"Amengual","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0595","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0600","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0025-7125(05)70509-5","article-title":"Pathogenesis and treatment of the antiphospholipid antibody syndrome","volume":"81","author":"Petri","year":"1997","journal-title":"Med Clin North Am"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0605","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.1997.00440390101013","article-title":"A retrospective review of 61 patients with antiphospholipid syndrome: Analysis of factors influencing recurrent thrombosis","volume":"157","author":"Krnic-Barrie","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0610","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-132-8-200004180-00005","article-title":"Potentiation of vitamin K antagonists by high dose intravenous methyl prednisolone","volume":"132","author":"Costedoat-Chalumeau","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0615","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/ndt\/15.11.1891","article-title":"Haemolytic uraemic syndrome, cardiomyopathy, cutaneous vasculopathy and anti-phospholipid activity","volume":"15","author":"Faria","year":"2000","journal-title":"Nephrol Dial Transpl"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0620","first-page":"271","article-title":"Reversible renal failure due to antiphospholipid antibody syndrome, pre-eclampsia and renal thrombotic microangiopathy","volume":"44","author":"Kon","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0625","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ndt\/16.4.843","article-title":"Life-threatening thrombosis 18 years after first presentation of primary antiphospholipid antibody syndrome","volume":"16","author":"Dupont","year":"2001","journal-title":"Nephrol Dial Transpl"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0630","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0049-3848(94)90270-4","article-title":"On the inhibitory effect of chloroquine on blood platelet aggregation","volume":"74","author":"Janicinova","year":"1994","journal-title":"Thromb Res"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0635","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0049-3848(95)00028-3","article-title":"Chloroquine inhibits stimulated platelets at the arachidonic acid pathway","volume":"77","author":"Nasal","year":"1995","journal-title":"Thromb Res"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0640","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"Edwards","year":"1997","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1046\/j.1523-1755.2002.00500.x_bb0645","first-page":"1551","article-title":"Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome","volume":"151","author":"Piette","year":"2000","journal-title":"Ann Med Intern"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0650","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1526-0968.2001.005001022.x","article-title":"Successful delivery in a pregnant woman with lupus anticoagulant positive systemic lupus erythematosus treated with double plasmapheresis","volume":"5","author":"Takeshita","year":"2001","journal-title":"Ther Apher"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0655","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1080\/03009742.1998.11720777","article-title":"Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: A review","volume":"107","author":"Harris","year":"1998","journal-title":"Scan J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0660","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/1529-0131(200104)44:4<876::AID-ANR144>3.0.CO;2-2","article-title":"Identification of an Fc receptor independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype","volume":"44","author":"Pierangeli","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2002.00500.x_bb0665","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-3083.1995.tb03649.x","article-title":"Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation","volume":"42","author":"Blank","year":"1995","journal-title":"Scan J Immunol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815486077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815486077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:45Z","timestamp":1733788845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815486077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":132,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0085253815486077"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00500.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}